Navigation Links
Studies Show Genetic Activity of Antioxidants
Date:7/21/2009

Clues found on how they help arteries stay clear and healthy

TUESDAY, July 21 (HealthDay News) -- Using the latest genetic technology, researchers have begun to discover the exact molecular reasons why foods such as turmeric -- a popular curry spice -- and ordinary orange juice are good for the health of hearts and arteries.

Two French research teams are reporting studies describing the range of genes that are affected by curcumin, the active ingredient in turmeric, and hesperidin, an antioxidant that is a prominent component of orange juice. Their reports were delivered at the American Heart Association's Basic Cardiovascular Sciences Conference 2009, held in Lake Las Vegas.

"We used a microarray approach," said Dragan Milenkovic, a research scientist at the Centre de Clermont-Ferrand/Thiex in Saint Genes Champanelle, who described the turmeric study. "We have slides with samples of all the genes and we compared the expression of each gene to see which of them had their activity modified by exposure to curcumin."

The molecular study was done with mouse genes, and was preceded by a trial in living mice. The researchers used curcumin, which is a polyphenol, a form of antioxidant. Like other antioxidants, curcumin is known to help prevent against arterial buildup of plaque, the fatty deposits that eventually can block blood vessels.

The molecular study was preceded by a trial in which mice given a daily curcumin supplement for 16 weeks were found to have a 26 percent lower level of fat deposits in the aorta, the main artery of the heart.

The researchers then isolated genetic material from the mice and exposed it to curcumin. They found altered expression of 2,252 genes, whose activity included cellular signaling and adhesion, inflammation and fat metabolism.

The orange juice study was done by a different team of researchers at the same institute, in human volunteers. Twenty-four men who
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Gene Studies of Male-Female Differences Often Flawed
2. Two studies published in the Lancet
3. Study of Studies Finds No Risk to Children From Phthalates in Toys
4. Just Completed Studies Reveal Impact of New Medicare Reimbursement Regulations
5. Studies Prove Exercise Can Heal the Body Mind and Soul
6. Studies Shed New Light on Breast Cancer, Treatment
7. Multi-Year Compendium of Pharmaceutical Case Studies Available from Best Practices, LLC
8. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
9. Best Practice Database: Complimentary Excerpt of Three Sales Force Excellence Studies
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Studies Show Genetic Activity of Antioxidants
Studies Show Genetic Activity of Antioxidants
(Date:11/24/2009)...RNewswire/--Whiletheholidayseasonoftenbringsfamili...anbedifficultforthosegrievingthedeathofalovedone.F...milies.Theholidayseasoncanbringadditionalchallenge...ce,ACenterforGrievingChildren,AdolescentsandTheirF...ontohavingavarietyofprintandonlineresourcesavailab...
(Date:11/24/2009)...Nov.24/PRNewswire/--Bionorica,aninternationalcompa...uncedtodaytheavailabilityofneweducationalresources...th.Atipsheeton"StayingNaturallyHealthyduringtheHol...wavailableonthecompany,swebsiteat www.bionoricausa...ubscriptiontotheNaturalMomstipsheets,withcontentco...
(Date:11/24/2009)...ewswire-FirstCall/--CenteneCorporation(NYSE: CNC )...hasselectedCenteneasoneoftwoCoordinatedCareOrganiz...ssNetwork(MississippiCAN),acoordinatedcareprogramf...gwiththeDivisiontoexecuteacontractinwhichthecompan...oliaHealthPlan(Magnolia). ,, BasedinJackson,Mis...
(Date:11/24/2009)...mproves heart prospects, but cancer risk remains ,...A new study offers yet more proof that smoking is ...nd cancer. , Researchers followed 12,152 Americ...mokers and nonsmokers for three years. During that... to die of cancer, 2.26 times more likely to die o...
(Date:11/24/2009)... have found that hormones produced during pregnanc...th of breast cancer. This protein, alpha-fetoprote...ent for the treatment and prevention of breast can...evention Research , a journal of the American Asso...gnancy, such as estrogen, all induce AFP, which di...
Breaking Medicine News(10 mins):Health News:Highmark Caring Place Resources Help Children and Families Who Are Grieving During the Holidays 2Health News:Bionorica Offers Expert Resources, Health Tips for 'Natural Moms' 2Health News:Centene Corporation Receives Notification of Intent to Contract From the State of Mississippi 2Health News:Smokers Double Their Risk for Heart Disease 2Health News:Protein from pregnancy hormone may prevent breast cancer 2
... N.J., April 15 MedQuist Inc. (Nasdaq: MEDQ ) t...ts new Chief Financial Officer. He joined MedQuis...t,s new CFO, Golio is responsible for directing al.... "Dominick,s broad experience as a Chief Financi...
...uck an industry trend and boost enrollments , , D...omy struggles, many health and fitness clubs conti...nchisees of Planet Fitness, however, the fastest g...ps totaling in the six figures. , , The campaign,...
...ons Give Employees More Flexibility and Ease Admin...The Guardian Life Insurance Company of America (Gu...ary benefits for small and mid-sized companies, to...rization, providing faster, easier access to impor...
...ological differences in toddlers born to drug abus...s) -- In what researchers are calling the first st...t women has been found to prompt abnormal brain de...pert said. , "If we accept the conclusion here tha...
...N.C., April 15 TSI Healthcare, a national leader ...election and implementation, and The SURVE Consult...resource firm, have announced a strategic alliance..., TSI (and its subsidiaries) currently has approxi...
...rdt and the Council for American Medical Innovatio...tion" in Chicago, featuring David Brennan, CEO of ...IO, academics and patient advocates , , CHICAGO,...atient advocacy to address the importance of medic...
Other Medicine News:Health News:MedQuist Names Dominick J. Golio as Chief Financial Officer 2Health News:Despite Ailing Economy, Planet Fitness Thrives 2Health News:New Program Gives Guardian Dental Pre-Paid/DHMO Members Greater Access to Specialty Care 2Health News:Fetal Exposure to Methamphetamine May Harm Child's Brain 2Health News:TSI Healthcare and SURVE Consulting Announce a Strategic Alliance for Leadership and Business Development 2Health News:Chicago's Top Minds Join National Business and Health Leaders in Addressing Medical Innovation, Highlighting Policies Needed to Maintain U.S. Competitiveness in Medical Science and Discovery 2Health News:Chicago's Top Minds Join National Business and Health Leaders in Addressing Medical Innovation, Highlighting Policies Needed to Maintain U.S. Competitiveness in Medical Science and Discovery 3Health News:Chicago's Top Minds Join National Business and Health Leaders in Addressing Medical Innovation, Highlighting Policies Needed to Maintain U.S. Competitiveness in Medical Science and Discovery 4
(Date:11/24/2009)...ciencesCorporationannouncedtodaythattherewillbemul...rationFLT3inhibitor,inAMLatthe51stAmericanSocietyo...LA,December5-8,2009.Anoralpresentationwillhighligh...tystudyinadultswithacutemyeloidleukemia(AML).Addit...heeffectofAC220monotherapyandincombinationwithchem...
(Date:11/24/2009)...FirstCall/--CardioGenicsHoldingsInc.(OTCBulletinBo...ngtheimmunoassaysegmentoftheIVDtestingmarket,repor...gtothenextphaseofthecommercializationofCardioGenic...). ,, PertheagreementwithMerckChimiethatwasexec...ewithitsproprietarysilvercoatedparamagneticbeadsfo...
(Date:11/24/2009)...Call/--EchoTherapeutics,Inc.(OTCBulletinBoard:ECTE...Systemasanon-invasive,wireless,transdermalcontinuo...inPrepSystemfortransdermaldrugdelivery,announcedto...iveOfficer,willpresentatthe13thAnnualBiotechandSpe...orkSocietyofSecuritiesAnalysts,at2:05onDecember1,2...
Breaking Medicine Technology:Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 2Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 3CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 3Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2Patch Shots May Someday Replace Injections 54893 1Patch Shots May Someday Replace Injections 54893 2Vanderbilt joins national consortium to develop new cancer therapies 54888 1Vanderbilt joins national consortium to develop new cancer therapies 54888 2Vanderbilt joins national consortium to develop new cancer therapies 54888 3American Society for Microbiology honors Anton Y Peleg 9618 1American Society for Microbiology honors Anton Y Peleg 9618 2American Society for Microbiology honors Anton Y Peleg 9618 3American Society for Microbiology honors Anton Y Peleg 9618 4
...re than 10 years, Mark Wentland, professor of chem...nic Institute , led a Rensselaer team in the disco...s with the potential to treat nervous system disor...censed to Alkermes Inc., and the company identifie...cal trials with the candidate, known as ALKS 33, b...
...en(TM), Inc. (NYSE Amex: ILE ) today announced t... ("FDA") has completed its initial review of the C...ated to its Nasolabial Fold/Wrinkles product candi...BLA for full review. , , In a communication recei...t it had completed its initial review of the Compa...
Other Medicine Technology:One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials 2One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials 3One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials 4One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials 5One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials 6Food and Drug Administration Accepts Isolagen's Biologics License Application for Full Review 2Food and Drug Administration Accepts Isolagen's Biologics License Application for Full Review 3
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: